Frederick Ruberg

24PUBLICATIONS
124CO-AUTHORS
Artificial life and complex adaptive systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 27, 2026
Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

|Apr 17, 2026
Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.

|Mar 26, 2025
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition.

Camille V Edwards, Grace M Ferri, Josue Villegas-Galaviz

|Jun 10, 2024
Mosaic Loss of the Y Chromosome Is Enriched in Patients With Wild-Type Transthyretin Cardiac Amyloidosis and Associated With Increased Mortality.

Mark C Thel, Jesse D Cochran, Sergio Teruya

|Jun 04, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.

Mathew S Maurer, Prem Soman, Adrian Hernandez

|Sep 25, 2023
Prognostic Value of Left Ventricular <sup>18</sup> F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis.

Olivier F Clerc, Yesh Datar, Sarah Am Cuddy

Pageof 4

Frequent Collaborators

8 joint publications

Vaishali Sanchorawala

6 joint publications

Andrew Staron

5 joint publications

Mathew S Maurer

4 joint publications

Lisa Mendelson